PMC:7228307 / 4118-4529
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 48 | 353-357 | Gene | denotes | FcγR | Gene:2213 |
| 49 | 141-145 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 164-170 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T46 | 141-143 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T47 | 241-251 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
| T48 | 350-352 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T49 | 353-355 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T12 | 99-107 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
| T13 | 275-280 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 46-55 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
| T21 | 178-182 | http://purl.obolibrary.org/obo/IDO_0000531 | denotes | host |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 48 | 353-357 | Gene | denotes | FcγR | Gene:2213 |
| 49 | 141-145 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T24 | 184-372 | Sentence | denotes | Thus, therapeutic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T10 | 164-170 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T24 | 184-372 | Sentence | denotes | Thus, therapeutic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7 |